Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer

1 Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial Annals of Oncology, May 20, 2013

2 Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer European Journal of Cancer, May 3, 2013

3 Meat-Related Mutagens and Pancreatic Cancer: null results from a clinic-based case-control study Cancer Epidemiology, Biomarkers & Prevention, May 2, 2013

4 Two Novel GATA6 Mutations Cause Childhood-Onset Diabetes Mellitus, Pancreas Malformation and Congenital Heart Disease Hormone Research in Paediatrics, April 26, 2013    Review Article

5 Biliary Findings Assist in Predicting Enlargement of Intraductal Papillary Mucinous Neoplasms of the Pancreas Clinical Gastroenterology and Hepatology , April 24, 2013

6 Risk for Mortality From Causes Other Than Pancreatic Cancer in Patients With Intraductal Papillary Mucinous Neoplasm of the Pancreas Pancreas, April 26, 2013

7 Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials Annals of Oncology, May 16, 2013

8 United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment World Journal of Gastroenterology, May 7, 2013

9 Management of Pancreatic Intraductal Papillary Mucinous Neoplasm in an Academic Hospital (2005-2010): What Follow-Up for Unoperated Patients Pancreas, May 6, 2013

10 Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial OncoTargets and Therapy, May 9, 2013